Doucey M A, Hess D, Cacan R, Hofsteenge J
Friedrich Miescher-Institut, CH-4002 Basel, Switzerland.
Mol Biol Cell. 1998 Feb;9(2):291-300. doi: 10.1091/mbc.9.2.291.
C-mannosylation of Trp-7 in human ribonuclease 2 (RNase 2) is a novel kind of protein glycosylation that differs fundamentally from N- and O-glycosylation in the protein-sugar linkage. Previously, we established that the specificity determinant of the acceptor substrate (RNase 2) consists of the sequence -x-x-W, where the first Trp becomes C-mannosylated. Here we investigated the reaction with respect to the mannosyl donor and the involvement of a glycosyltransferase. C-mannosylation of Trp-7 was reduced 10-fold in CHO (Chinese hamster ovary) Lec15 cells, which are deficient in dolichyl-phosphate-mannose (Dol-P-Man) synthase activity, compared with wild-type cells. This was not a result of a decrease in C-mannosyltransferase activity. Rat liver microsomes were used to C-mannosylate the N-terminal dodecapeptide from RNase 2 in vitro, with Dol-P-Man as the donor. This microsomal transferase activity was destroyed by heat and protease treatment, and displayed the same acceptor substrate specificity as the in vivo reaction studied previously. The C-C linkage between the indole and the mannosyl moiety was demonstrated by tandem electrospray mass spectrometry analysis of the product. GDP-Man, in the presence of Dol-P, functioned as a precursor in vitro with membranes from wild-type but not CHO Lec15 cells. In contrast, with Dol-P-Man both membrane preparations were equally active. It is concluded that a microsomal transferase catalyses C-mannosylation of Trp-7, and that the minimal biosynthetic pathway can be defined as: Man -> -> GDP-Man -> Dol-P-Man -> (C2-Man-)Trp.
人核糖核酸酶2(RNase 2)中色氨酸-7的C-甘露糖基化是一种新型蛋白质糖基化,在蛋白质-糖连接方面与N-和O-糖基化有根本区别。此前,我们确定受体底物(RNase 2)的特异性决定因素由序列-x-x-W组成,其中第一个色氨酸会发生C-甘露糖基化。在此,我们研究了甘露糖基供体的反应以及糖基转移酶的作用。与野生型细胞相比,缺乏多萜醇磷酸甘露糖(Dol-P-Man)合酶活性的中国仓鼠卵巢(CHO)Lec15细胞中,色氨酸-7的C-甘露糖基化降低了10倍。这并非C-甘露糖基转移酶活性降低的结果。使用大鼠肝脏微粒体在体外以Dol-P-Man作为供体对RNase 2的N端十二肽进行C-甘露糖基化。这种微粒体转移酶活性经加热和蛋白酶处理后被破坏,并且显示出与先前研究的体内反应相同的受体底物特异性。通过对产物的串联电喷雾质谱分析证实了吲哚与甘露糖基部分之间的C-C连接。在Dol-P存在的情况下,GDP-Man在体外可作为野生型细胞而非CHO Lec15细胞膜的前体发挥作用。相比之下,对于Dol-P-Man,两种膜制剂的活性相同。结论是微粒体转移酶催化色氨酸-7的C-甘露糖基化,并且最小生物合成途径可定义为:甘露糖 -> GDP-甘露糖 -> Dol-P-甘露糖 -> (C2-甘露糖基化的)色氨酸。